| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| May 26, 2020 | May 27, 2020 | Stejbach Mark Dir | Buy | Flexion Therapeutics Inc | FLXN | $9.75 | $19,997 | +36.10% |
| Feb 16, 2018 | Feb 21, 2018 | Stejbach Mark SVP Chief Comm Off Alks Inc | Sell | Alkermes Plc. | ALKS | $70.5 | $767,092 | -19.08% |
| Jun 16, 2017 | Jun 20, 2017 | Stejbach Mark Dir | Buy | Flexion Therapeutics Inc | FLXN | $17.02 | $26,888 | +50.00% |
| Jun 08, 2017 | Jun 08, 2017 | Stejbach Mark SVP Chief Comm Off Alks Inc | Sell | Alkermes Plc. | ALKS | $60.34 | $603,352 | -18.51% |
| Jan 09, 2017 | Jan 10, 2017 | Stejbach Mark SVP Chief Comm Off Alks Inc | Sell | Alkermes Plc. | ALKS | $60.27 | $32,968 | -1.58% |
| Jan 04, 2017 | Jan 07, 2017 | Stejbach Mark SVP Chief Comm Off Alks Inc | Sell | Alkermes Plc. | ALKS | $60.05 | $567,687 | -21.70% |
| Dec 28, 2015 | Dec 28, 2015 | Stejbach Mark Chief Commercial Officer | Sell | Alkermes Plc. | ALKS | $80.24 | $802,392 | -33.82% |
| Dec 01, 2015 | Dec 02, 2015 | Stejbach Mark Chief Commercial Officer | Sell | Alkermes Plc. | ALKS | $72.18 | $1M | -47.92% |
| Nov 02, 2015 | Nov 04, 2015 | Stejbach Mark Chief Commercial Officer | Sell | Alkermes Plc. | ALKS | $72.06 | $1M | -47.41% |